Fredericks: Trump's fight against cancer puts patients first

The article argues that President Trump’s cancer agenda is shifting from treating cancer after it appears to pushing earlier detection and prevention. It highlights the Right to Try Act, and the administration’s Make America Healthy Again (MAHA) movement, which focuses attention on lifestyle risk factors including poor diet, excessive alcohol and physical inactivity through the MAHA Commission. A central focus is innovative screening for cancers that lack traditional tests—such as pancreatic, ovarian and liver—using multi-cancer early detection blood tests. The FDA is evaluating Galleri, and an advisory committee recently voted in favor of approval. Legislation signed earlier this year could enable Medicare access. The FDA’s National Priority Voucher Program is also cited for accelerating promising treatments, including an early approval for metastatic pancreatic cancer.